![Page 1: Diagnostic Capabilities Beyond the Tumor Cell Genome Gregory J. Tsongalis, PhD, HCLD Professor of Pathology Director, Molecular Pathology Geisel School](https://reader036.vdocument.in/reader036/viewer/2022062320/56649c7e5503460f949345c3/html5/thumbnails/1.jpg)
Diagnostic Capabilities Beyond the Tumor Cell Genome
Gregory J. Tsongalis, PhD, HCLD
Professor of Pathology
Director, Molecular PathologyGeisel School of Medicine at Dartmouth
Dartmouth Hitchcock Medical CenterNorris Cotton Cancer Center
Lebanon, NH
![Page 2: Diagnostic Capabilities Beyond the Tumor Cell Genome Gregory J. Tsongalis, PhD, HCLD Professor of Pathology Director, Molecular Pathology Geisel School](https://reader036.vdocument.in/reader036/viewer/2022062320/56649c7e5503460f949345c3/html5/thumbnails/2.jpg)
Outline
• Technology and Personalized Medicine
• miRNAs
• The liquid biopsy
• Beyond that…….
![Page 3: Diagnostic Capabilities Beyond the Tumor Cell Genome Gregory J. Tsongalis, PhD, HCLD Professor of Pathology Director, Molecular Pathology Geisel School](https://reader036.vdocument.in/reader036/viewer/2022062320/56649c7e5503460f949345c3/html5/thumbnails/3.jpg)
Technology and Therapeutics as Drivers of Medical Care
Basic Science
Clinical Medicine
Translational Research
Clinical Laboratory Medicine
![Page 4: Diagnostic Capabilities Beyond the Tumor Cell Genome Gregory J. Tsongalis, PhD, HCLD Professor of Pathology Director, Molecular Pathology Geisel School](https://reader036.vdocument.in/reader036/viewer/2022062320/56649c7e5503460f949345c3/html5/thumbnails/4.jpg)
The Genome Or The Human Karyotype
![Page 5: Diagnostic Capabilities Beyond the Tumor Cell Genome Gregory J. Tsongalis, PhD, HCLD Professor of Pathology Director, Molecular Pathology Geisel School](https://reader036.vdocument.in/reader036/viewer/2022062320/56649c7e5503460f949345c3/html5/thumbnails/5.jpg)
Massively Parallel or Next Generation Sequencing at DHMC
MiSeq PGM
Sequence by Synthesis
![Page 6: Diagnostic Capabilities Beyond the Tumor Cell Genome Gregory J. Tsongalis, PhD, HCLD Professor of Pathology Director, Molecular Pathology Geisel School](https://reader036.vdocument.in/reader036/viewer/2022062320/56649c7e5503460f949345c3/html5/thumbnails/6.jpg)
Personalized Medicine
Shaw A T and Engelman J A JCO 2013;31:1105-1111
(A) Before crizotinib; (B) after 7 weeks of crizotinib.
![Page 7: Diagnostic Capabilities Beyond the Tumor Cell Genome Gregory J. Tsongalis, PhD, HCLD Professor of Pathology Director, Molecular Pathology Geisel School](https://reader036.vdocument.in/reader036/viewer/2022062320/56649c7e5503460f949345c3/html5/thumbnails/7.jpg)
NucleusNucleus
CytoplasmCytoplasm
Pri-miRNAPri-miRNA Pre-miRNAPre-miRNA
miRNA:mimiRNA:miRNA* RNA*
duplexduplexUnwindingUnwinding
DroshaDroshaDGCR8DGCR8
Exportin 5Exportin 5
DicerDicer
RISCRISC
RibosomeRibosome
Translational RepressionTranslational Repression mRNA CleavagemRNA Cleavage
C. L. Bartels and G.J. Tsongalis, Clin Chem, 2009;55: 623-631
Specificity(miRNAs as Biomarkers)
![Page 8: Diagnostic Capabilities Beyond the Tumor Cell Genome Gregory J. Tsongalis, PhD, HCLD Professor of Pathology Director, Molecular Pathology Geisel School](https://reader036.vdocument.in/reader036/viewer/2022062320/56649c7e5503460f949345c3/html5/thumbnails/8.jpg)
miRNA Profiling from Pancreatic FNAs
Szafranska, Doleshal, Edmunds , Gordon , Luttges, Mundingv Barth Jr , Gutmann, Siriawinata , Pipas , Tannapfel , Korc, Hahn, Labourier , Tsongalis . Clin Chem 54(10):1716-1724, 2008.
5
16
4
5
*
** **
Hanoun, Delpu, Suriawinata, Bournet, Bureau, Selves, Tsongalis , Dufresne, Buscail, Cordelier, Torrisani. Clin Chem 56(7):1107-1118, 2010.
24 FFPE matched tumor and normal HNSCC (6 laryngeal, 6 oral tongue)
miRs: 21, 205, 12746 upregulatedmiRs:451, 125b downregulated
![Page 9: Diagnostic Capabilities Beyond the Tumor Cell Genome Gregory J. Tsongalis, PhD, HCLD Professor of Pathology Director, Molecular Pathology Geisel School](https://reader036.vdocument.in/reader036/viewer/2022062320/56649c7e5503460f949345c3/html5/thumbnails/9.jpg)
Issues With The Tissues
– Tumor tissue has inherent limitations– Tumor tissue is a single snapshot in time– Selection bias due to tumor heterogeneity– Invasive procedure
![Page 10: Diagnostic Capabilities Beyond the Tumor Cell Genome Gregory J. Tsongalis, PhD, HCLD Professor of Pathology Director, Molecular Pathology Geisel School](https://reader036.vdocument.in/reader036/viewer/2022062320/56649c7e5503460f949345c3/html5/thumbnails/10.jpg)
Resected Specimen Small Needle Core Biopsy
Exhausted Block
A Huge Problem
![Page 11: Diagnostic Capabilities Beyond the Tumor Cell Genome Gregory J. Tsongalis, PhD, HCLD Professor of Pathology Director, Molecular Pathology Geisel School](https://reader036.vdocument.in/reader036/viewer/2022062320/56649c7e5503460f949345c3/html5/thumbnails/11.jpg)
The Liquid Biopsy
• Cell Free DNA (cfDNA)–Cells undergoing apoptosis or necrosis–Amount of cfDNA correlates with tumor staging and prognosis
![Page 13: Diagnostic Capabilities Beyond the Tumor Cell Genome Gregory J. Tsongalis, PhD, HCLD Professor of Pathology Director, Molecular Pathology Geisel School](https://reader036.vdocument.in/reader036/viewer/2022062320/56649c7e5503460f949345c3/html5/thumbnails/13.jpg)
Xenograft Model
Kerrington Smith, MD
![Page 14: Diagnostic Capabilities Beyond the Tumor Cell Genome Gregory J. Tsongalis, PhD, HCLD Professor of Pathology Director, Molecular Pathology Geisel School](https://reader036.vdocument.in/reader036/viewer/2022062320/56649c7e5503460f949345c3/html5/thumbnails/14.jpg)
Promega PlexorHY
![Page 15: Diagnostic Capabilities Beyond the Tumor Cell Genome Gregory J. Tsongalis, PhD, HCLD Professor of Pathology Director, Molecular Pathology Geisel School](https://reader036.vdocument.in/reader036/viewer/2022062320/56649c7e5503460f949345c3/html5/thumbnails/15.jpg)
J. E. Hill, PhDThayer School of Engineering at Dartmouth
Breath-based Diagnostics
![Page 16: Diagnostic Capabilities Beyond the Tumor Cell Genome Gregory J. Tsongalis, PhD, HCLD Professor of Pathology Director, Molecular Pathology Geisel School](https://reader036.vdocument.in/reader036/viewer/2022062320/56649c7e5503460f949345c3/html5/thumbnails/16.jpg)
Breath-based Diagnostics
![Page 17: Diagnostic Capabilities Beyond the Tumor Cell Genome Gregory J. Tsongalis, PhD, HCLD Professor of Pathology Director, Molecular Pathology Geisel School](https://reader036.vdocument.in/reader036/viewer/2022062320/56649c7e5503460f949345c3/html5/thumbnails/17.jpg)
Conclusions
• Circulating nucleic acids become future biomarkers of choice
• More advanced analysis of simpler specimens
![Page 18: Diagnostic Capabilities Beyond the Tumor Cell Genome Gregory J. Tsongalis, PhD, HCLD Professor of Pathology Director, Molecular Pathology Geisel School](https://reader036.vdocument.in/reader036/viewer/2022062320/56649c7e5503460f949345c3/html5/thumbnails/18.jpg)
Molecular Pathology Laboratory and Translational Research Program
Samantha AllenPaul Burchard
Francine de Abreu, Ph.D.Leanne CookBetty Dokus
Amber ErskineTorrey Gallagher
Arnold HawkJoel Lefferts, Ph.D.
Emmeline LiuRebecca O’MearaJason Peterson
Elizabeth ReaderBarbara Soares
Heather SteinmetzLaura Tafe, M.D.Scott Turner, PhDWendy Wells, M.D.
Terri WilsonEric York